Posted by AI on 2025-09-30 13:19:25 | Last Updated by AI on 2026-08-22 03:14:09
Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 14
In a move that has sent shockwaves through the Indian Premier League (IPL) community, United Spirits Limited (USL) has put the iconic Royal Challengers Bangalore (RCB) franchise up for sale, with a staggering valuation of 17,762 crore ($2 billion). This revelation has sparked intense interest from potential buyers, with Serum Institute of India's CEO, Adar Poonawalla, emerging as a leading contender.
The RCB franchise, a powerhouse in the IPL, has been a fan favorite since its inception in 2008. With a star-studded lineup over the years, including legends like Virat Kohli, AB de Villiers, and Chris Gayle, the team has consistently drawn massive crowds and a dedicated fan base. However, the decision to sell comes as a surprise, especially considering the team's recent success, reaching the IPL playoffs in 2022.
Adar Poonawalla, known for his business acumen and passion for cricket, is reportedly keen to add the prestigious RCB franchise to his portfolio. Poonawalla, a prominent figure in the healthcare industry, has expressed his desire to diversify his investments, and the IPL franchise seems to be an attractive prospect. The Serum Institute's success in the vaccine manufacturing sector has positioned Poonawalla as a serious bidder, with the financial muscle to meet the franchise's hefty price tag.
As the news spreads, cricket enthusiasts and industry experts eagerly await the outcome of this high-profile auction. The sale of RCB could mark a significant shift in the IPL landscape, potentially impacting team dynamics and the league's overall brand value. With Poonawalla's interest, the franchise's future seems bright, promising continued success and a new chapter in the IPL's rich history. The auction process is expected to be closely watched, as the league's stakeholders and fans anticipate the next move in this billion-dollar game.